Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amneal Pharmaceuticals Inc (AMRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,512,741
  • Shares Outstanding, K 298,470
  • Annual Sales, $ 775,790 K
  • Annual Income, $ -469,290 K
  • 36-Month Beta 1.41
  • Price/Sales 7.21
  • Price/Cash Flow 8.98
  • Price/Book 5.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.27
  • Number of Estimates 7
  • High Estimate 0.29
  • Low Estimate 0.25
  • Prior Year 0.23
  • Growth Rate Est. (year over year) +17.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.24 +7.13%
on 10/16/18
24.35 -24.15%
on 09/21/18
-4.34 (-19.03%)
since 09/17/18
3-Month
17.24 +7.13%
on 10/16/18
24.48 -24.55%
on 08/22/18
-0.22 (-1.18%)
since 07/17/18
52-Week
13.47 +37.12%
on 05/09/18
24.48 -24.55%
on 08/22/18
-0.83 (-4.30%)
since 10/17/17

Most Recent Stories

More News
Lannett Set to Lose Distribution Agreement With Key Supplier

Lannett Company's (LCI) distribution agreement with key supplier, Jerome Stevens Pharmaceuticals, not to be renewed on expiry. Shares plunge.

LCI : 4.13 (-0.72%)
ENDP : 17.05 (-6.83%)
AMRX : 18.47 (unch)
BSTC : 61.10 (-0.99%)
Company News For Aug 21, 2018

Companies In The News are: EL,COP,PX,AMRX

COP : 72.48 (-1.79%)
EL : 128.82 (+0.26%)
PX : 159.79 (-0.55%)
AMRX : 18.47 (unch)
Amneal Pharmaceuticals (AMRX) Jumps: Stock Rises 5.6%

Amneal Pharmaceuticals (AMRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

ENDP : 17.05 (-6.83%)
AMRX : 18.47 (unch)
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 4.35% and -0.28%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

AMRX : 18.47 (unch)
Amneal: 2Q Earnings Snapshot

HAYWARD, Calif. (AP) _ Amneal Pharmaceuticals, Inc. (AMRX) on Thursday reported a loss of $19.1 million in its second quarter.

AMRX : 18.47 (unch)
Amneal and Impax Complete Business Combination

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. ("Impax") today announced that they have completed their business combination to form Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company"). As...

IPXL : 18.30 (unch)
AMRX : 18.47 (unch)
Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600

Apergy Corp. (NYSE: APY) will replace 3D Systems Corp. (NYSE: DDD) in the S&P MidCap 400, and 3D Systems will replace Impax Laboratories Inc. (NASD: IPXL) in the S&P SmallCap 600 effective prior to the...

DDD : 18.16 (+1.57%)
IPXL : 18.30 (unch)
SPGI : 190.63 (+0.39%)
APY : 42.79 (-2.53%)
DOV : 82.23 (-1.21%)
AMRX : 18.47 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade AMRX with:

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

2nd Resistance Point 19.76
1st Resistance Point 19.11
Last Price 18.47
1st Support Level 17.57
2nd Support Level 16.68

See More

52-Week High 24.48
Fibonacci 61.8% 20.27
Fibonacci 50% 18.98
Last Price 18.47
Fibonacci 38.2% 17.68
52-Week Low 13.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar